drugset / Trial / NCT01486732

FLT-PET Activity Change After Allogeneic Umbilical Cord Blood (UCB) Therapy in Cerebral Palsy

NCT01486732 ↗

Phase 2 Withdrawn Bundang CHA Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is randomized placebo-controlled trial to recognize new cell regeneration in the brain using FLT-PET.

Timeline

Start
2013-03
Primary completion
2014-04
Completion
2014-07

Outcome

Outcome not reported

Stopped: “Difficulty in obtaining specific isotope tracer”

Drugs

EvaluationDrugModalityDoseRoute
Subject Umbilical Cord Blood Infusion Cell therapy — Intravenous

Indications